Drawing for U-DOTS

USPTO serial 85844978

U-DOTS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BRADLEY, EVELYN
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with U-DOTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shauna M. Wertheim

SHAUNA M WERTHEIM THE MARBURY LAW GROUP PLLC11800 SUNRISE VALLEY DRFL 15RESTON, VA 20191 5300

Goods and services

ClassDescriptionStatusFirst use
042Scientific research dealing with fluorescent tags and labels; laboratory research services in the fields of biomedicine, biophotonics, pharmaceuticals, cosmetics, and material research, namely, development of composite materials with photonic properties; product development in which fluorescent tagging is used; graphic design services for others; laboratory research, development and testing in the fields of biomedicine, pharmaceuticals, cosmetics, and material science and engineering; scientific research in the nature of mapping of samples for scientific purposes, namely, to visualize the presence of specific substances within the samples using fluorescent labels; computer software development related to identification of fluorescent tags; scientific research, laboratory research and development of new products which require fluorescent tagging, labeling, and tracing, all in the fields of clinical diagnostic assays, clinical diagnostic tests, disease screening, genetic disease screening, disease identification, genetic disease identification, disease testing, genetic disease testing, mutation detection, mutation screening, mutation scanning, genomics, functional genomics, genome testing, genome analysis, genotyping, gene testing, gene identification, gene analysis, gene screening, gene interaction screening, gene expression, gene mapping, genetic marker identification, genetic trait determination, plant genetics, genetic modifications, genetically modified organisms, genetically modified products, DNA fingerprinting, nucleic acid testing, nucleic acid analysis, identity testing, human identity testing, person identification, donor identification, tissue typing, tissue matching, parentage testing, paternity testing, forensics, pharmaceuticals, pharmaceutical testing, pharmaceutical identification, agriculture, agricultural products, quality testing of seed samples of plants, purity testing of plant seed samples, and quality control of plant seed samples and information and consultation services in connection therewith; research and development in the field of biotechnology, specifically relating to conducting protein expression and purification, which require fluorescent tagging for separation, using mammalian, Baculovirus insect cell, E. coli, and yeast cell expression systems for protein expression and purification, large scale protein production in a gram scale, antibody production, hybridoma and in vitro monoclonal antibody production, antibody fragmentation, antibody labeling, protein modification, and PEGylationABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2014MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Oct 7, 2014ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 7, 2014OP.TOPPOSITION TERMINATED NO. 999999—
Oct 7, 2014OP.SOPPOSITION SUSTAINED NO. 999999—
Jul 1, 2014OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 14, 2014ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 4, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 4, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 12, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 29, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 29, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 13, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 13, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 13, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 13, 2014ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 13, 2013GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 13, 2013GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 13, 2013CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 19, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 19, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2013ALIEASSIGNED TO LIE—
Jun 5, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2013DOCKASSIGNED TO EXAMINER—
Feb 15, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED—
Feb 14, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 12, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance